Stay updated on Gilead Sciences Press Releases

Sign up to get notified when there's something new on the Gilead Sciences Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Gilead Sciences Press Releases page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Gilead Sciences has announced a significant partnership with PEPFAR to deliver Lenacapavir for HIV prevention, alongside launching a new campaign highlighting the experiences of people living with HIV. Additionally, Gilead has broken ground on a new manufacturing hub as part of its growth strategy.
    Difference
    79%
    Check dated 2025-09-07T13:36:27.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now includes an update on the European Commission's authorization of Yeytuo® (Lenacapavir) for HIV prevention, replacing the previous information about Yeztugo® (Lenacapavir) being the first FDA-approved option.
    Difference
    82%
    Check dated 2025-08-31T11:34:46.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated with significant new content regarding Gilead Sciences, including announcements about financial results, product approvals, and partnerships related to HIV prevention. Notably, Yeztugo® (Lenacapavir) is now highlighted as the first FDA-approved HIV prevention option offering six months of protection.
    Difference
    100%
    Check dated 2025-08-24T07:28:45.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The webpage has removed significant financial and product announcement details related to Gilead Sciences, including key dates and results that could impact stakeholders.
    Difference
    59%
    Check dated 2025-08-17T01:11:06.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect Gilead Sciences' announcement of their second quarter 2025 financial results, replacing the previous update regarding the FDA's approval of a new indication for Biktarvy.
    Difference
    9%
    Check dated 2025-08-09T19:54:10.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page now includes a new FDA approval for Biktarvy for treatment-experienced individuals with HIV, while the previous information about Trodelvy and Keytruda has been removed.
    Difference
    94%
    Check dated 2025-08-02T15:22:59.000Z thumbnail image

Stay in the know with updates to Gilead Sciences Press Releases

Enter your email address, and we'll notify you when there's something new on the Gilead Sciences Press Releases page.